← Open Payments lookup

THOMAS GRAVES: Open Payments

NPI 1942729819 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$334 in 16 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $367 · 2025 $334

Food & beverage: $334
CompanyPaymentsAmount
BioCryst US Sales Co., LLC3$101
CSL Behring2$34
GlaxoSmithKline, LLC.2$33
ARS Pharmaceuticals Operations, Inc.2$32
AstraZeneca Pharmaceuticals LP1$25
Genentech USA, Inc.1$24
Regeneron Healthcare Solutions, Inc.1$20
Ionis Pharmaceuticals, Inc.1$17
Amgen Inc.1$16
Novartis Pharmaceuticals Corporation1$16

Products named: ORLADEYO, NUCALA, NEFFY, AIRSUPRA, Xolair, DUPIXENT, Hizentra, TEZSPIRE.

Industry payments across DE — which companies pay providers there.